Document Detail

The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder - A systematic review.
MedLine Citation:
PMID:  24405794     Owner:  NLM     Status:  Publisher    
The management of problem behaviours (PB) in individuals with intellectual disabilities (ID), developmental disabilities (DD) and/or autistic spectrum disorders (ASD) can be challenging. Antipsychotic medications are commonly prescribed where other strategies have failed. A systematic review (SR) was conducted to establish the research evidence for the efficacy of aripiprazole in the management of PB in adults and children with ID, DD and/or ASD. Although included studies supported the efficacy of aripiprazole for this indication, the overall quality of studies was poor. Of the 20 studies included in this systematic review there were only two randomised controlled trials (RCTs) on children with ASD and/or ID/DD, both of which were conducted by the pharmaceutical company that manufactures aripiprazole, and it is not clear whether a number of same participants were included in both RCTs. One of the RCTs was extended into an open label long term follow up, which showed that aripiprazole's efficacy lasted over 52 weeks and the adverse effects were tolerable. Four studies were open label prospective studies, 11 were retrospective case reports which included four single case reports, and two were prospective case series. Most studies reported adverse effects from aripiprazole in the form of weight gain, increased appetite, sedation, tiredness, drooling and tremor. However, aripiprazole improved serum prolactin level in some participants and overall did not show any adverse effect on QTc interval. There is a need for more carefully designed RCTs into the use of aripiprazole in the management of PB in people with ID/DD and/or ASD, which should be carried out independent of pharmaceutical companies.
Shoumitro Deb; Baldeep K Farmah; Ebrahim Arshad; Tanya Deb; Meera Roy; Gemma L Unwin
Related Documents :
15074344 - Onychotillomania: 2 case reports.
8286284 - Urokinase therapy in mesenteric venous thrombosis: a case study.
9833714 - Paracoccidioidomycotic aortitis with embolization to the lower limbs. report of a case ...
15270604 - Large esophageal liposarcoma: a case report and review of the literature.
23323074 - Prosthetic tricuspid valve thrombosis: three case reports and literature review.
12656274 - Intramedullary spinal cord metastases: case report and review of literature.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-6
Journal Detail:
Title:  Research in developmental disabilities     Volume:  -     ISSN:  1873-3379     ISO Abbreviation:  Res Dev Disabil     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-1-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709782     Medline TA:  Res Dev Disabil     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Highly resilient coping entails better perceived health, high social support and low morning cortiso...
Next Document:  Comparison of interventions for pain control with tenaculum placement: a randomized clinical trial.